CV Therapeutics
also invests · investor profileFoster City, US · 12 known investors
Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries. The company combines scientific rigor with global partnerships and licensing programs to expand access to medicines worldwide.
Founders & leadership
Investors · 12
Aisling CapitalNew York
Asset Management CompanyMenlo Park · $500K – $2M
Frazier Life SciencesPalo Alto
Kleiner PerkinsMenlo Park · $500K – $15M
Longitude CapitalMenlo Park · $10M – $30M
Lumira VenturesToronto · $1M – $10M
Menlo VenturesSan Francisco · $1M – $20M
Monograph Capital PartnersLondon
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Ridgeback CapitalMiami
RiverVest Venture PartnersSt. Louis · $500K – $3M
VantagePoint Capital PartnersSilicon Valley · $2M – $100M
Competitors · 2
by search overlap
Medscape850 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Johnson & Johnson600 shared keywordsJohnson & Johnson develops prescription medicines and medical technology across areas including oncology, immunology, neuroscience, cardiopulmonary, cardiovascular, orthopaedics, surgery, and vision. Its two main businesses, Innovative Medicine and MedTech, focus on treating complex diseases through science-based drugs and less invasive, personalized medical devices.
Companies competing with CV Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does CV Therapeutics do?
- Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries. The company combines scientific rigor with global partnerships and licensing programs to expand access to medicines worldwide.
- Who founded CV Therapeutics?
- CV Therapeutics was founded by Lou Lange, Michael L. Riordan.
- Who are CV Therapeutics's investors?
- CV Therapeutics's investors include Aisling Capital, Asset Management Company, Frazier Life Sciences, Kleiner Perkins, Longitude Capital, Lumira Ventures, Menlo Ventures, Monograph Capital Partners and 4 more.
- Where is CV Therapeutics headquartered?
- CV Therapeutics is headquartered in Foster City, US.